Fed's Goolsbee Warns on Inflation, Pfizer Trial Fails, IBM Soars on AI Partnership

Market News
1. Fed official Goolsbee stated that inflation is still well above target and moving the wrong way, with services inflation being a bit disturbing.
2. Pfizer shares fell 1% after a Phase 3 study for Sigvotatug Vedotin failed to show an improvement in overall survival.
3. IBM shares rose 2% following an announcement of collaboration with OpenAI for an AI offering in enterprise cyber defense.